检索历史清除

首页> Contemporary clinical trials> Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC)

Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC)

导出原文传递

翻译打印收藏纠错

作者： Nekljudova, Valentina ^[1] ; Loibl, Sibylle ^[2] ; von Minckwitz, Gunter ^[3] ; Schneeweiss, Andreas ; Gluck, Stefan ; Crane, Richard ; Li, Huiling ; Luo, Xiaolong

作者单位： Celgene Corp, 86 Morris Ave, Summit, NJ 07901 USA ^[1] Univ Klinikum, German Breast Grp, Neu Isenberg, Heidelberg, Germany ^[2] Celgene Corp, Stockley Pk, England ^[3]

发布时间 2019-04-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交